Mobisante Launches MobiUS™ TC2 Tablet, Driving Innovation in Mobile Ultrasound

Share Article

MobiUS TC2 clinical grade tablet embodies point-of-care ultrasound, improving affordability and access.

MobiSante Logo
“We’re providing a cost-effective and portable point-of-care device that is ideal for physician offices, community hospitals, rural and remote locations, as well as disaster relief organizations.”

Mobisante today announced the release of the MobiUS TC2 ultrasound imaging system. Consistent with Mobisante’s innovative product development approach, the MobiUS TC2 is easy to use, portable, and affordable, allowing fast, accessible ultrasound diagnosis. Transforming healthcare with mobile technology, the MobiUS TC2 is small, lightweight and battery powered, making ultrasound a viable option virtually anywhere.

“We’re providing a cost-effective and portable point-of-care device that is ideal for physician offices, community hospitals, rural and remote locations, as well as disaster relief organizations,” said Dr. Sailesh Chutani, CEO, Mobisante. The portable device has an intuitive user interface and is extremely versatile, helping aid in routine screenings, trauma, abdominal or pelvic pain, musculoskeletal procedures and diagnoses, OB/GYN assessment, and ultrasound-guided procedures. The MobiUS TC2 utilizes a certified (EN60601-1) medical grade tablet that offers a handle for easy carrying, antimicrobial-coated display, and a multi-function docking station.

Mobisante is uniquely situated to tap into the mobile, ultrasound, and global health expertise in the Puget Sound area. “Companies like Mobisante are emblematic of Washington’s leadership in Global Health. They are introducing cutting edge technologies for the front lines of medicine where we can make health care better, more efficient, less expensive and more responsive to the needs of our patients and care providers,” said Dr. Garrison Bliss, Founder of Qliance, a direct primary care pioneer based in Seattle.

Mobisante has won several international and national awards for product innovation and has been featured on CNN, The MIT Technology Review, The New York Times, The Economist, Bloomberg, Seattle Times, and Xconomy, amongst others.

Mobisante’s MobiUS TC2 is a game changer for point-of-care service: it puts the power of ultrasound technology within the economic reach of healthcare professionals everywhere. Even smaller, resource-constrained facilities can consider adding ultrasound to their capabilities, significantly improving patient care. To learn more about getting the MobiUS TC2 visit or call 425-605-0600.

For information about Mobisante and the MobiUS TC2 tablet, connect with us:

About Mobisante
Mobisante, based in Redmond, Washington, aims to transform medical imaging by making safe, simple, non-invasive, and affordable ultrasound technology available to a broad range of clinicians. This allows them to move imaging closer to the point of patient care, which has been shown to improve clinical outcomes and efficiency in healthcare delivery. By leveraging the steadily increasing power and ubiquity of advanced, standards based mobile computing technology, Mobisante is able to provide simpler, more flexible and lower cost solutions in contrast to the expensive and complex products that previously limited broad access to point of care medical imaging. Mobisante’s first product, the MobiUS SP1, became the first smartphone-based ultrasound-imaging device to be cleared by the FDA.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Elise Worthy
+1 2066123079
Email >
Visit website